Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161

被引:0
|
作者
Jenny M Mjösberg
Sara Trifari
Natasha K Crellin
Charlotte P Peters
Cornelis M van Drunen
Berber Piet
Wytske J Fokkens
Tom Cupedo
Hergen Spits
机构
[1] Tytgat Institute for Liver and Intestinal Research,Department of Immunology
[2] University of Amsterdam,Department of Otorhinolaryngology
[3] Genentech,Department of Experimental Immunology and Pulmonology of the Academic Medical Center
[4] University of Amsterdam,Department of Hematology
[5] University of Amsterdam,undefined
[6] Erasmus University Medical Center,undefined
[7] Present address: La Jolla Institute for Allergy and Immunology,undefined
[8] La Jolla,undefined
[9] California,undefined
[10] USA (S.T.),undefined
[11] and Pfizer at Rinat,undefined
[12] San Francisco,undefined
[13] California,undefined
[14] USA (N.K.C.).,undefined
来源
Nature Immunology | 2011年 / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Mice have lineage-negative IL-7Rα+ (innate lymphoid) cells that contribute to type 2 immunity. Spits and colleagues identify a similar CRTH2+CD161+ population in human lungs and gut that produces IL-13 after stimulation.
引用
收藏
页码:1055 / 1062
页数:7
相关论文
共 50 条
  • [1] Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161
    Mjosberg, Jenny M.
    Trifari, Sara
    Crellin, Natasha K.
    Peters, Charlotte P.
    van Drunen, Cornelis M.
    Piet, Berber
    Fokkens, Wytske J.
    Cupedo, Tom
    Spits, Hergen
    NATURE IMMUNOLOGY, 2011, 12 (11) : 1055 - U56
  • [2] IL-33-Responsive Lineage-CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs
    Bartemes, Kathleen R.
    Iijima, Koji
    Kobayashi, Takao
    Kephart, Gail M.
    McKenzie, Andrew N.
    Kita, Hirohito
    JOURNAL OF IMMUNOLOGY, 2012, 188 (03): : 1503 - 1513
  • [3] IL-33-Responsive Group 2 Innate Lymphoid Cells Are Regulated by Female Sex Hormones in the Uterus
    Bartemes, Kathleen
    Chen, Chien-Chang
    Iijima, Koji
    Drake, Li
    Kita, Hirohito
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01): : 229 - 236
  • [4] Lineage-Sca1+c-Kit-CD25+ Cells Are IL-33-Responsive Type 2 Innate Cells in the Mouse Bone Marrow
    Brickshawana, Adipong
    Shapiro, Virginia Smith
    Kita, Hirohito
    Pease, Larry R.
    JOURNAL OF IMMUNOLOGY, 2011, 187 (11): : 5795 - 5804
  • [5] Differential regulation of type 2 innate lymphoid cells by IL-25 and IL-33
    Chen, Chien-Chang
    Iijima, Koji
    Kobayashi, Takao
    Kita, Hirohito
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [6] Macrophages as IL-25/IL-33-Responsive Cells Play an Important Role in the Induction of Type 2 Immunity
    Yang, Zhonghan
    Grinchuk, Viktoriya
    Urban, Joseph F., Jr.
    Bohl, Jennifer
    Sun, Rex
    Notari, Luigi
    Yan, Shu
    Ramalingam, Thirumalai
    Keegan, Achsah D.
    Wynn, Thomas A.
    Shea-Donohue, Terez
    Zhao, Aiping
    PLOS ONE, 2013, 8 (03):
  • [7] IL-33-Responsive Innate Lymphoid Cells Are an Important Source of IL-13 in Chronic Rhinosinusitis with Nasal Polyps
    Shaw, Joanne L.
    Fakhri, Samer
    Citardi, Martin J.
    Porter, Paul C.
    Corry, David B.
    Kheradmand, Farrah
    Liu, Yong-Jun
    Luong, Amber
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (04) : 432 - 439
  • [8] IL-33-and IL-25-responsive innate lymphoid cells are present in human peripheral blood.
    Bartemes, Kathleen
    Fox, Stephanie
    Kita, Hirohito
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [9] Cutting Edge: CCR8 Signaling Regulates IL-25-and IL-33-Responsive Skin Group 2 Innate Lymphoid Cell Migration and Function
    Sun, Zhengwang
    Han, Sen
    Zhu, Xueping
    Islam, Sabina A.
    JOURNAL OF IMMUNOLOGY, 2023, 211 (12): : 1751 - 1755
  • [10] IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells
    Camelo, Ana
    Rosignoli, Guglielmo
    Ohne, Yoichiro
    Stewart, Ross A.
    Overed-Sayer, Catherine
    Sleeman, Matthew A.
    May, Richard D.
    BLOOD ADVANCES, 2017, 1 (10) : 577 - 589